Kenneth Lin

Kenneth Lin

Directeur/Membre du Conseil chez ANEBULO PHARMACEUTICALS, INC.

Fortune : - $ au 31/05/2026

53 ans
Finance
Health Technology
Consumer Services

Profil

Kenneth S.
Lin
was the founder of Ab Initio Biotherapeutics, Inc. (2015) and served as President & Chief Executive Officer from 2015 to 2019.
Current jobs include Independent Director at Anebulo Pharmaceuticals, Inc. since 2021 and Advisor at Tarrant Capital IP LLC since 2008.
Former jobs include Director at Vibrynt, Inc., Director at Conventus Orthopaedics, Inc., VP-Corporate Development & Investor Relations at Ulthera, Inc. from 2012 to 2014, Research Associate at Goldman Sachs & Co. LLC from 2000 to 2002, Associate at J.P.
Morgan Partners LLC, Associate at Panorama Capital LLC, and Vice President at TPG, Inc. from 2008 to 2012.
Education includes an undergraduate degree from Stanford University (1994) and a doctorate from Case Western Reserve University (1999).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/09/2025 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Kenneth Lin

SociétésPosteDébut
ANEBULO PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/02/2021
Corporate Officer/Principal 13/06/2012

Anciens postes connus de Kenneth Lin

SociétésPosteFin
Directeur Général 01/07/2019
Investor Relations Contact 01/07/2014
TPG INC. Corporate Officer/Principal 01/06/2012
Corporate Officer/Principal 31/12/2007
Analyst-Equity 31/12/2002
Voir l'expérience en détail de Kenneth Lin

Formation de Kenneth Lin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

95

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Services

Consumer Services

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Kenneth Lin